Keywords: Pfizer, Zoetis, SPin-off, IPO, BGI-Shenzhen, Complete Genomics, Tender offer extended, M&A, USA, China

Pfizer's Zoetis spin-off could raise $12 billion; BGI-Shenzhen updates on Complete Genomics deal

Article | 20 January 2013

Print This

Pfizer (NYSE: PFE), the world’s largest drugmaker by sales, which has previously said it is spinning off its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in